Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Martina Garau"'
Autor:
Patricia Cubi-Molla, David Mott, Nadine Henderson, Bernarda Zamora, Mendel Grobler, Martina Garau
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 21, Iss 1, Pp 1-18 (2023)
Abstract Background The value of a life is regularly monetised by government departments for informing resource allocation. Guidance documents indicate how economic evaluation should be conducted, often specifying precise values for different impacts
Externí odkaz:
https://doaj.org/article/c5f9496ac3204f349804b7abe9132359
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 14, Iss 1, Pp 1-12 (2019)
Abstract Objectives The primary objective of this study was to compare the availability and access of orphan medicinal products (OMPs) in the devolved nations in the United Kingdom (UK), France, Germany, Italy and Spain. Availability is defined as th
Externí odkaz:
https://doaj.org/article/7b612a1ac22c4a4b9a57713dfb10861f
Publikováno v:
BMJ Global Health, Vol 5, Iss 4 (2020)
Externí odkaz:
https://doaj.org/article/0e779498379a40e397d2aabfc7066a1c
Autor:
Henk Broekhuizen, Kevin Marsh, Hector Castro, Leon Bijlmakers, Mohammedreza Mobinizadeh, Janine Astrid van Til, Monika Wagner, Michele Tringali, Andrew J. Mirelman, Alireza Olyaeemanesh, Irina Cleemput, Maarten Jansen, Joice Valentim, Agnes Toll, Rob Baltussen, Alec Morton, Vakaramoko Diaby, Praveen Thokala, Sitaporn Youngkong, Georgi Iskrov, V. Zah, Martina Garau, Wija Oortwijn
Publikováno v:
Value in Health, 22, 1283-1288
Value in health, 22(11), 1283-1288. Elsevier
Value in Health, 22, 11, pp. 1283-1288
Value in health, 22(11), 1283-1288. Elsevier
Value in Health, 22, 11, pp. 1283-1288
Objective Recent years have witnessed an increased interest in the use of multicriteria decision analysis (MCDA) to support health technology assessment (HTA) agencies for setting healthcare priorities. However, its implementation to date has been cr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4bec22c3aed85f869b8f4d0a5fcd8b3
https://hdl.handle.net/2066/212262
https://hdl.handle.net/2066/212262
Publikováno v:
BMJ Global Health, Vol 5, Iss 4 (2020)
BMJ Global Health
BMJ Global Health
Summary box Tuberculosis (TB), an infectious disease primarily affecting poor and neglected populations, kills an estimated 1.6 million men, women and children each year).1 Our existing arsenal of tools is insufficient to address this enormous burden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2d6a848775afc5f0262c3adfe72cb0c
https://gh.bmj.com/content/5/4/e002061.full
https://gh.bmj.com/content/5/4/e002061.full
Publikováno v:
International Journal of Technology Assessment in Health Care. 37:19-19
IntroductionThe European Union regulation for orphan medicinal products (OMPs) was introduced to improve the quality of treatments for patients with rare conditions. To mark 20 years of European Union OMP regulation, this study compared access to OMP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18accdda4746854ca677375665d0490e
https://doi.org/10.1017/s0266462321001124
https://doi.org/10.1017/s0266462321001124
Publikováno v:
PharmacoEconomics Open
Background Healthcare decision makers need to make trade-offs between different elements of value of new treatments. Multicriteria decision analysis (MCDA) provides a framework that can help decision makers to understand stakeholders’ preferences a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ff930d717034a9cf4ebbf022dbee3d0
http://europepmc.org/articles/PMC5972119
http://europepmc.org/articles/PMC5972119
Publikováno v:
Journal of Comparative Effectiveness Research. 4:401-418
Aim: Explore key factors influencing future expectations for the production of evidence of relative effectiveness (RE) for drugs in Europe in 2020; construct three plausible future scenarios for RE evidence generation. Materials & methods: Semi-struc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56495cddf4a3eef2cc995438f04253bc
https://doi.org/10.2217/cer.15.7
https://doi.org/10.2217/cer.15.7
The future of comparative effectiveness and relative efficacy of drugs: an international perspective
Publikováno v:
Journal of Comparative Effectiveness Research. 4:419-427
Drug development takes place in a global marketplace, albeit with the USA and EU markets currently dominating. In the USA, demands for comparative effectiveness research have gained traction against a backdrop of health delivery reform, while Europea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e6d946a0dedf1a7437777e19e1ef585
https://doi.org/10.2217/cer.15.8
https://doi.org/10.2217/cer.15.8